Drug information for TRI-NORINYL 21-DAY

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL-21 0.035MG,0.035MG,0.035MG;0.5MG,1MG,0.5MG Discontinued   ETHINYL ESTRADIOL; NORETHINDRONE Norethindrone WATSON LABS 18977

Drug Adverse Effects information for TRI-NORINYL 21-DAY

Role code Indications Reaction # Reports
C CONTRACEPTION ARTHRALGIA 2
C CONTRACEPTION DEEP VEIN THROMBOSIS 2
C CONTRACEPTION MENTAL DISORDER 2
C CONTRACEPTION MUSCLE STRAIN 2
C CONTRACEPTION PAIN 2
Ads by Google